Skip to main content
SpringerLink
Log in

Arterial therapies of colorectal cancer metastases to the liver

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Intra-arterial therapies directed to the liver take advantage that liver tumors are fed by the hepatic artery while the liver vascularization is 30% arterial. Most common techniques of intra-arterial therapies for colorectal cancer liver metastases (CRLM) include intra-arterial hepatic chemotherapy (IAHC), transarterial chemoembolization (TACE), and radioembolization. Such treatments are used as salvage therapies because they provide response when systemic therapies are inefficient. They are also used as a first line therapy to produce maximal response in order to convert the patient from non-surgical to surgical. IAHC with FUDR or oxaliplatinum allow 90% response rate and conversion to surgery of 40% to 50% of initially inoperable patients. TACE is used in CRLM with promising response rate, namely due to the use of drug eluting beads that can be loaded with irinotecan which can elute the drug they contain after embolization in liver tumor. Radioembolization is a unique way of delivering a high tumoricidal dose of radiation (>100 Gy) to liver tumor without harming the healthy liver, and provided interesting results in salvage therapy, enough to be evaluated today in a randomized control trial in first line therapy where FOLFOX is proposed with and without additional radioembolization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Refrences

  1. Folprecht G, Grothey A, Alberts S, Raab Hr, Kohne Ch (2005) Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 16:1311–1319

    Article  PubMed  CAS  Google Scholar 

  2. Herrmann Ka, Waggershauser T, Sittek H, Reiser Mf (2000) Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology 215:294–299

    PubMed  CAS  Google Scholar 

  3. Tanaka T, Arai Y, Inaba Y, et al. (2003) Radiologic placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 14:63–68

    Article  PubMed  Google Scholar 

  4. Zanon C, Grosso M, Clara R, et al. (2001) Combined regional and systemic chemotherapy by a mini-invasive approach for the treatment of colorectal liver metastases. Am J Clin Oncol 24:354–359

    Article  PubMed  CAS  Google Scholar 

  5. Habbe TG, Mccowan TC, Goertzen TC, et al. (1998) Complications and technical limitations of hepatic arterial infusion catheter placement for chemotherapy. J Vasc Interv Radiol 9:233–239

    Article  PubMed  CAS  Google Scholar 

  6. Deschamps F, Rao P, Teriitehau C, et al. (2010) Percutaneous femoral implantation of an arterial port catheter for intraarterial chemotherapy: feasibility and predictive factors of long-term functionality. J Vasc Interv Radiol 21:1681–1688

    Article  PubMed  Google Scholar 

  7. Aldrighetti L, Arru M, Angeli E, et al. (2002) Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy. Hepatogastroenterology 49:513–517

    PubMed  Google Scholar 

  8. Deschamps F, Elias D, Goere D, et al. (2010) Intra-arterial hepatic chemotherapy: a comparison of percutaneous versus surgical implantation of port-catheters. Cardiovasc Intervent Radiol 9:9

    Google Scholar 

  9. Meta-Analysis Group in Cancer (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252–258

    Google Scholar 

  10. Kemeny Ne, Niedzwiecki D, Hollis Dr, et al. (2006) Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24:1395–1403

    Article  PubMed  CAS  Google Scholar 

  11. Boige V, Malka D, Elias D, et al. (2008) Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann Surg Oncol 15:219–226

    Article  PubMed  Google Scholar 

  12. Kemeny N, Jarnagin W, Paty P, et al. (2005) Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 23:4888–4896

    Article  PubMed  CAS  Google Scholar 

  13. Kemeny NE, Melendez FD, Capanu M, et al. (2009) Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 27:3465–3471

    Article  PubMed  Google Scholar 

  14. Malka D, Paris E, Caramella C, et al. (2010) Combined hepatic oxaliplatin, intravenous LV5FU2 and erbitux. Proc ASCO 2010: abstr 3558

  15. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236

    Article  PubMed  Google Scholar 

  16. Kudo M, Okanoue T (2007) Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 72(Suppl 1):2–15

    Article  PubMed  Google Scholar 

  17. Nakakuma K, Tashiro S, Hiraoka T, Ogata K, Ootsuka K (1985) Hepatocellular carcinoma and metastatic cancer detected by iodized oil. Radiology 154:15–17

    PubMed  CAS  Google Scholar 

  18. Konno T, Maeda H, Iwai K, et al. (1984) Selective targeting of anti-cancer drugs and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium. Cancer 54:2367–2374

    Article  PubMed  CAS  Google Scholar 

  19. De Baere T, Dufaux J, Roche A, et al. (1995) Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study. Radiology 194:165–170

    PubMed  CAS  Google Scholar 

  20. Egawa H, Maki A, Mori K, et al. (1990) Effects of intra-arterial chemotherapy with a new lipophilic anticancer agent, estradiol-chlorambucil (KM2210), dissolved in lipiodol on experimental liver tumor in rats. J Surg Oncol 44:109–114

    Article  PubMed  CAS  Google Scholar 

  21. Kruskal Jb, Hlatky L, Hahnfeldt P, et al. (1993) In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors. J Vasc Interv Radiol 4:741–747

    Article  PubMed  CAS  Google Scholar 

  22. Aliberti C, Tilli M, Benea G, Fiorentini G (2006) Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res 26:3793–3795

    PubMed  CAS  Google Scholar 

  23. Hong K, Khwaja A, Liapi E, et al. (2006) New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12:2563–2567

    Article  PubMed  CAS  Google Scholar 

  24. Van Riel JM, Van Groeningen CJ, De Greve J, et al. (2004) Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver. Ann Oncol 15:59–63

    Article  PubMed  Google Scholar 

  25. Jordan O, Denys A, De Baere T, Boulens N, Doelker E (2010) Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan. J Vasc Interv Radiol 21:1084–1090

    Article  PubMed  Google Scholar 

  26. Taylor Rr, Tang Y, Gonzalez Mv, Stratford Pw, Lewis Al (2007) Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 30:7–14

    Article  PubMed  CAS  Google Scholar 

  27. Rao P, Pascale F, Seck A, et al. (2009) Evaluation of modes of irinotecan administration in a rabbit Vx-2 tumour model: early pharmacokinetics and tumour response. Abst. Cardiovascular and Interventinal radiological society meeting 2009

  28. Brown Kt (2004) Fatal pulmonary complications after arterial embolization with 40–120- micro m tris-acryl gelatin microspheres. J Vasc Interv Radiol 15:197–200

    Article  PubMed  Google Scholar 

  29. Muller H, Nakchbandi V, Chatzisavvidis I, Von Voigt C (2003) Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases. Hepatogastroenterology 50:1919–1926

    PubMed  CAS  Google Scholar 

  30. Fiorentini G, Alibert C, Benea G, et al. (2009) Evaluation at 16 months of a phase III study comparing TACE-DC beads IRI loaded (DEBIRI) with FOLFIRI (CT) for patients with nonresectable colorectal cancer (CRC) liver metastases (LM). Abst 4092 (ASCO meeting)

  31. Martin Rc, Robbins K, Tomalty D, et al. (2009) Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol 7:80

    Article  PubMed  Google Scholar 

  32. Bower M, Metzger T, Robbins K, et al. (2010) Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study. HPB (Oxford) 12:31–36

    Google Scholar 

  33. Fiorentini G, Aliberti C, Montagnani F, et al. (2010) Trans-arterial chemoembolization of metastatic colorectal carcinoma (MCRC) to the liver adopting polyvinyl alcohol microspheres (PAM) loaded with irinotecan compared with FOLFIRI (CT): evaluation at two years of a phase III clinical trial. Abst 588: ESMO 2010

  34. Martin Rc, Howard J, Tomalty D, et al. (2010) Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry. Cardiovasc Intervent Radiol 33:960–966

    Article  PubMed  CAS  Google Scholar 

  35. Fiorentini G, Aliberti C, Benea G, et al. (2008) TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects. Hepatogastroenterology 55:2077–2082

    PubMed  CAS  Google Scholar 

  36. Hong K, Mcbride JD, Georgiades CS, et al. (2009) Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol 20:360–367

    Article  PubMed  Google Scholar 

  37. Dawson L, Mcginn C, Ormolle D (2000) Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18:2210–2218

    PubMed  CAS  Google Scholar 

  38. Kennedy A, Nutting C, Coldwell D, et al. (2004) Pathologic response and microdosimetry of 90Y-microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60:1552–1563

    Article  PubMed  CAS  Google Scholar 

  39. Campbell A, Bailey I, Burton M (2001) Tumour dosimetry in human liver following hepatic 90Y-microsphere therapy. Phys Med Biol 46:487–498

    Article  PubMed  CAS  Google Scholar 

  40. Kennedy AS, Coldwell D, Nutting C, et al. (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65:412–425

    Article  PubMed  CAS  Google Scholar 

  41. Jakobs T, Hoffmann R, Dehm K, et al. (2008) Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol 19:1187–1195

    Article  PubMed  Google Scholar 

  42. Vente M, Wondergem M, Van Der Tweel I, et al. (2009) Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19:951–959

    Article  PubMed  CAS  Google Scholar 

  43. Cosimelli M, Golfieri R, Cagol P, et al. (2010) Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. Br J Cancer 103:324–331

    Article  PubMed  CAS  Google Scholar 

  44. Van Hazel G, Blackwell A, Anderson J, et al. (2004) Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88:78–85

    Article  PubMed  Google Scholar 

  45. Hendlisz A, Van Den Eynde M, Peeters M, et al. (2010) Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol 28:3687–3694

    Article  PubMed  CAS  Google Scholar 

  46. Sharma R, Van Hazel G, Morgan B, et al. (2007) Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 25:1099–1106

    Article  PubMed  CAS  Google Scholar 

  47. Van Hazel G, Pavlakis N, Goldstein D, et al. (2009) Treatment of fluorouracil refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol 27:4089–4095

    Article  PubMed  Google Scholar 

  48. Nicolay N, Berry D, Sharma R (2009) Liver metastases from colorectal cancer: radioembolization with systemic therapy. Nat Rev Clin Oncol 6:687–697

    Article  PubMed  CAS  Google Scholar 

  49. Gray B, Van Hazel G, Hope M, et al. (2001) Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12:1711–1720

    Article  PubMed  CAS  Google Scholar 

  50. Kennedy A, Mcneillie P, Dezarn W, et al. (2009) Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 74:1494–1500

    Article  PubMed  CAS  Google Scholar 

  51. Naymagon S, Warner R, Patel K, et al. (2010) Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature. Dig Dis Sci 55:2450–2458

    Article  PubMed  Google Scholar 

  52. Ogawa F, Mino-Kenudson M, Shimizu M, et al. (2008) Gastroduodenitis associated with yttrium 90: microsphere selective internal radiation: an iatrogenic complication in need of recognition. Arch Pathol Lab Med 2008:1734–1738

    Google Scholar 

  53. Kennedy A, Salem R, Nag S, et al. (2007) Recommendations for radioembolization of hepatic malignancies using Yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68:13–23

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Interventional Radiology, Institut Gustave Roussy, Villejuif, France

    Thierry de Baere & Frederic Deschamps

Authors
  1. Thierry de Baere
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frederic Deschamps
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thierry de Baere.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Baere, T., Deschamps, F. Arterial therapies of colorectal cancer metastases to the liver. Abdom Imaging 36, 661–670 (2011). https://doi.org/10.1007/s00261-011-9768-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-011-9768-z

Keywords

Search

Navigation